选择地区语言
Through fast, non-invasive and convenient genetic testing methods, it identifies a small number of high-risk groups for cancer from large asymptomatic populations—especially for cancers with high incidence/mortality rates and long progression periods. For tumor early screening based on genetic testing, its core advantages include early detection, coverage of multiple cancer types, high user compliance, and relatively high specificity compared to traditional methods.
Platform Advantages
SE75 sequencing takes only 4.5 h, the competitive sequencing speed will keep your project running more smoothly.
Sequencers, flow cells and reagents are self-developed and produced in-house, ensuring reliable delivery.
Building on the company’s years of expertise in microbiology, this platform includes a database of over 20,000 microbial species.
Compatible with mainstream libraries on the market, eliminating debugging costs.
Sikun Integrated NGS Solution
Integrates Extraction, Library Construction, and Quality Control in One System.
Eliminates Tedious Operational Procedures, Ultra-Simple Operation.
Reduces analysis time to accelerate
critical clinical and research decisions.
